Language in Primary Progressive Aphasia
ConditionPrimary Progressive Aphasia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNorthwestern University
About this trial
The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of primary progressive aphasia
Right-handed
Native English speaker
Visual acuity of 20/30 corrected
Disqualifiers
Left-handedness
Claustrophobia
Presence of significant medical illness that initially or in the future could interfere with continued participation in the study
Trial population
Participants with PPA will be recruited from the Northwestern University Alzheimer's Disease Center Core registry, the Northwestern University Neurobehavior and Memory Clinic, and from those who contact the center that are interested in PPA research.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsGroup A: PPA (Primary Progressive Aphasia)
Group B: Control
Trial outcomes
Primary outcomes
1
Neuropsychological variables
Time frame
Immediately after testing and at two years post-testingSponsors and contacts
Click on the lead sponsor to view all of their trials.
Northwestern University
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov